13th Nov 2006 07:30
Tepnel Life Sciences PLC13 November 2006 FOR IMMEDIATE RELEASE Tepnel Life Sciences plc ("Tepnel" or the "Company") Announcement of R&D Day for shareholders Manchester, UK. 13th November 2006; Tepnel Life Sciences plc (AIM: TED), theUK-based international Molecular Diagnostics and Research Products & Servicesgroup, announces that it will be holding an R&D day on Thursday December 7th2006 to update shareholders on the development of future products and services. Date: Thursday 7th December 2006Time: 9.00am - 1.00pmVenue: The Royal Society of Medicine Lower Atrium Theatre 1 Wimpole Street, London. W1G 0AE United Kingdom Full details can we found in the Investor Relations section at www.tepnel.com. To register, contact Joanna Dixon at De Facto Communications. Please send her anemail ([email protected] ) or call her on +44 (0)20 7861 3042. Enquiries: Ben Matzilevich, Chief Executive Officer, Tepnel Life Sciences plc 0161 946 2200Mark Percy, Seymour Pierce Limited 0207 107 8000Richard Anderson, De Facto Communications Ltd 0207 861 3838 About Tepnel Life Sciences plc: Tepnel is a UK-based international life sciences company focused on moleculardiagnostics and research products and services including DNA purification kitsand reagents, scientific services for nucleic acid purification, drug analysis,genotyping and genetically modified foods. Tepnel was founded in 1992 to exploitDNA technology generated at UMIST (University of Manchester Institute of Scienceand Technology) and is quoted on the AIM segment of the London Stock Exchange(AIM: TED). More information on Tepnel can be found at www.tepnel.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TED.L